LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 21.40 84.90 1346 1454 0.9253 0.9625
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 21.40 84.90 42 1454 0.0289 -0.1578
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 21.40 84.90 1381 1454 0.9494 0.9748
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.10 84.90 92 1616 0.0569 0.0191
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.10 84.90 1447 1616 0.8953 0.9486
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.10 84.90 60 1616 0.0371 -0.0784
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.10 84.90 1480 1616 0.9157 0.9590
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 24.81 84.90 106 1769 0.0599 0.0520
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 24.81 84.90 1608 1769 0.9087 0.9568
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 24.81 84.90 78 1769 0.0441 -0.0192
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 24.81 84.90 1593 1769 0.9003 0.9526
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 26.51 84.90 130 1923 0.0676 0.0993
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 26.51 84.90 1711 1923 0.8897 0.9487
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 26.51 84.90 97 1923 0.0504 0.0300
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 26.51 84.90 1618 1923 0.8413 0.9247
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 28.21 84.90 153 2091 0.0732 0.1359
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 28.21 84.90 1747 2091 0.8353 0.9236
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 28.21 84.90 100 2091 0.0478 0.0361
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 28.21 84.90 1703 2091 0.8142 0.9130
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 29.92 84.90 170 2237 0.0760 0.1585
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 29.92 84.90 1881 2237 0.8406 0.9278
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 29.92 84.90 135 2237 0.0603 0.1033
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 29.92 84.90 1877 2237 0.8388 0.9269
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 31.62 84.90 182 2449 0.0743 0.1702
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 31.62 84.90 2085 2449 0.8511 0.9346
MN20160318_Q02
C19